Karl Harlos

Karl Harlos

Auto-generated profile, based on publicly available information

Karl Harlos

University of Oxford

Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Science Advances
Verified
Journal Article
Open access
PDF file
TVTrine V. Vendelboe
Trine V. Vendelboe
PHPernille Harris
Pernille Harris
Yuguang ZhaoYuguang Zhao
Yuguang Zhao
TWThomas S. Walter
Thomas S. Walter
KHKarl Harlos
Karl Harlos
HCHans E. M. Christensen
Hans E. M. Christensen
This first structure of the enzyme converting dopamine to norepinephrine provides new perspectives on numerous disorders.

19 February 2019 in Nature Communications
Verified
Journal Article
Open access
PDF file
KOKamel El Omari
Kamel El Omari
SLSai Li
Sai Li
AKAbhay Kotecha
Abhay Kotecha
TWThomas S. Walter
Thomas S. Walter
Eduardo Andres BignonEduardo Andres Bignon
Eduardo Andres Bignon
ERElina Roine
Elina Roine
Lipid membrane fusion is an essential function in many biological processes. Detailed mechanisms of membrane fusion and the protein structures involved have been mainly studied in eukaryotic systems, whereas very little is known about membrane fusion in prokaryotes. Haloarchaeal pleomorphic viruses (HRPVs) have a membrane envelope decorated with spikes that are presumed to be responsible for host attachment and membrane fusion. Here we determine atomic structures of the ectodomains of the 57-kDa spike protein VP5 from two related HRPVs revealing a previously unreported V-shaped fold. By Volta phase plate cryo-electron tomography we show that VP5 is monomeric on the viral surface, and we establish the orientation of the molecules with respect to the viral membrane. We also show that the viral membrane fuses with the host cytoplasmic membrane in a process mediated by VP5. This sheds light on protein structures involved in prokaryotic membrane fusion.

2 March 2018 in Science Advances
Verified
Journal Article
Open access
PDF file
TNTao Ni
Tao Ni
SWSophie I. Williams
Sophie I. Williams
SRSaša Rezelj
Saša Rezelj
GAGregor Anderluh
Gregor Anderluh
KHKarl Harlos
Karl Harlos
RGRobert J. C. Gilbert
Robert J. C. Gilbert
Structures of Toxoplasma perforin-like protein facilitate understanding of the protein’s role in infection and disease.

28 March 2022 in Communications Biology
Verified
Journal Article
Open access
PDF file
DLDapeng Li
Dapeng Li
SBSimon Brackenridge
Simon Brackenridge
LWLucy C. Walters
Lucy C. Walters
OSOlivia Swanson
Olivia Swanson
KHKarl Harlos
Karl Harlos
BHBarton F. Haynes
Barton F. Haynes
The non-classical class Ib molecule human leukocyte antigen E (HLA-E) has limited polymorphism and can bind HLA class Ia leader peptides (VL9). HLA-E-VL9 complexes interact with the natural killer (NK) cell receptors NKG2A-C/CD94 and regulate NK cell-mediated cytotoxicity. Here we report the isolation of 3H4, a murine HLA-E-VL9-specific IgM antibody that enhances killing of HLA-E-VL9-expressing cells by an NKG2A+NK cell line. Structural analysis reveal that 3H4 acts by preventing CD94/NKG2A docking on HLA-E-VL9. Upon in vitro maturation, an affinity-optimized IgG form of 3H4 showes enhanced NK killing of HLA-E-VL9-expressing cells. HLA-E-VL9-specific IgM antibodies similar in function to 3H4 are also isolated from naïve B cells of cytomegalovirus (CMV)-negative, healthy humans. Thus, HLA-E-VL9-targeting mouse and human antibodies isolated from the naïve B cell antibody pool have the capacity to enhance NK cell cytotoxicity.

5 June 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
DRDaniel Rozbesky
Daniel Rozbesky
MVMarieke G Verhagen
Marieke G Verhagen
DKDimple Karia
Dimple Karia
GNGergely N Nagy
Gergely N Nagy
LALuis Alvarez
Luis Alvarez
EJEdith Yvonne Jones
Edith Yvonne Jones
Semaphorin ligands interact with plexin receptors to contribute to functions in the development of myriad tissues including neurite guidance and synaptic organisation within the nervous system. Cell‐attached semaphorins interact in trans with plexins on opposing cells, but also in cis on the same cell. The interplay between trans and cis interactions is crucial for the regulated development of complex neural circuitry, but the underlying molecular mechanisms are uncharacterised. We have discovered a distinct mode of interaction through which the Drosophila semaphorin Sema1b and mouse Sema6A mediate binding in cis to their cognate plexin receptors. Our high‐resolution structural, biophysical and in vitro analyses demonstrate that monomeric semaphorins can mediate a distinctive plexin binding mode. These findings suggest the interplay between monomeric vs dimeric states has a hereto unappreciated role in semaphorin biology, providing a mechanism by which Sema6s may balance cis and trans functionalities.

12 January 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSManmohan Sharma
Manmohan Sharma
NMNipun Malhotra
Nipun Malhotra
MYManickam Yogavel
Manickam Yogavel
KHKarl Harlos
Karl Harlos
BMBruno Melillo
Bruno Melillo
ASAmit Sharma
Amit Sharma
The inhibition of Plasmodium cytosolic phenylalanine tRNA-synthetase (cFRS) by a novel series of bicyclic azetidines has shown the potential to prevent malaria transmission, provide prophylaxis, and offer single-dose cure in animal models of malaria. To date, however, the molecular basis of Plasmodium cFRS inhibition by bicyclic azetidines has remained unknown. Here, we present structural and biochemical evidence that bicyclic azetidines are competitive inhibitors of L-Phe, one of three substrates required for the cFRS-catalyzed aminoacylation reaction that underpins protein synthesis in the parasite. Critically, our co-crystal structure of a PvcFRS-BRD1389 complex shows that the bicyclic azetidine ligand binds to two distinct sub-sites within the PvcFRS catalytic site. The ligand occupies the L-Phe site along with an auxiliary cavity and traverses past the ATP binding site. Given that BRD1389 recognition residues are conserved amongst apicomplexan FRSs, this work lays a structural framework for the development of drugs against both Plasmodium and related apicomplexans.